S&P 500's Top Gainer Dethroned After Trial Data, FANG Weakness

(Bloomberg) -- A technology stock-led selloff may be contributing to weakness in Abiomed Inc. shares after its study of its Impella heart pump in patients who suffer a dangerous form of heart attac...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.